<html>
<head>PUBMED IDs for FBXO33</head>
<body bgcolor='#C5F0F2'><h1>FBXO33</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20648246/'>Severe Progressive Autism Associated with Two de novo Changes: A 2.6-Mb 2q31.1 Deletion and a Balanced t(14;21)(q21.1;p11.2) Translocation with Long-Range Epigenetic Silencing of LRFN5 Expression.</a> July 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/25284319/'>Case-control genome-wide association study of persistent attention-deficit hyperactivity disorder identifies FBXO33 as a novel susceptibility gene for the disorder.</a> January 6  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26915486/'>Genetic analysis of advanced glycation end products in the DHS MIND study.</a> August 27  2016<br></body></html>
